# Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Study · id `cardio:ct-nct05966662` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05966662](<https://clinicaltrials.gov/study/NCT05966662>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05966662

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.

## Technical summary

Registry record NCT05966662. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-08 (actual); primary completion 2025-01-09 (actual). Results posted on 2026-01-28.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 145 participants (enrolled count; ClinicalTrials.gov record NCT05966662, source copy `cardio:ctgov-nct05966662-2026-02-24`, retrieved 2026-10-26)
- Started: 2023-12-08 (actual) (ClinicalTrials.gov record NCT05966662, source copy `cardio:ctgov-nct05966662-2026-02-24`, retrieved 2026-10-26)
- Primary completion: 2025-01-09 (actual) (ClinicalTrials.gov record NCT05966662, source copy `cardio:ctgov-nct05966662-2026-02-24`, retrieved 2026-10-26)
- Completion: 2025-12-19 (actual) (ClinicalTrials.gov record NCT05966662, source copy `cardio:ctgov-nct05966662-2026-02-24`, retrieved 2026-10-26)
- Results first posted: 2026-01-28 (ClinicalTrials.gov record NCT05966662, source copy `cardio:ctgov-nct05966662-2026-02-24`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05966662, source copy `cardio:ctgov-nct05966662-2026-02-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05966662-2026-02-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)
- Condition: Coronary Artery Disease
- Condition: Myocardial Infarction
- Intervention (Device): IVL with Shockwave C2+ 2Hz Coronary IVL Catheter
- Lead sponsor: Shockwave Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Shockwave Medical, Inc. (`cardio:org-shockwave-medical-inc`)

## Provenance

Content hash: 4bba8036f3121ebf31576f3984f80613d63b5d9cab0921e2c4a588458653b723
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
